<DOC>
	<DOCNO>NCT01110681</DOCNO>
	<brief_summary>The study evaluate safety efficacy Solesta injectable bulking agent treatment fecal incontinence total 24 month complete treatment .</brief_summary>
	<brief_title>Study Evaluate Solesta Treatment Fecal Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>1880 year age , male female Screening fecal incontinence severity score ( CCFIS ) Fecal incontinence episodes 28day period Failed conservative treatment fecal incontinence Complete external sphincter disruption Significant anorectal disease Anorectal surgery within last 12 month prior study Active Inflammatory Bowel Disease Immunodeficiency receive immunosuppressive therapy Malignancies remission le 1 year prior study Bleeding disorder receive anticoagulant therapy Chemotherapy within last 6 month prior study Prior Pelvic radiotherapy Pregnant breastfeeding woman , woman childbearing potential practicing adequate contraception plan stop contraception within first year study Women within 6 month post partum Participation clinical study within 3 month prior study Other severe condition way unsuitable participate accord investigator judgement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>